Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses

Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses

Abstract Background Non-small cell lung cancer (NSCLC) is the major type of lung cancer with high morbidity and poor prognosis. Erlotinib, an inhibitor of epidermal growth factor receptor (EGFR), has been clinically applied for NSCLC treatment. Nevertheless, the erlotinib acquired resistance of NSCL...

Full description

Bibliographic Details
Main Authors: Huyue Zhou, Qiumei Xiang, Changpeng Hu, Jing Zhang, Qian Zhang, Rong Zhang
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Hereditas
Subjects:
Bioinformatics analyses
NSCLC
Erlotinib resistance
MMP1
Online Access:http://link.springer.com/article/10.1186/s41065-020-00145-x

Similar Items

Similar Items